CA 15-3

  • Item #: E584
  * Marked fields are required.
Price $59.00
Useful For: Predicting early recurrence in women treated for carcinoma
of the breast. The Food and Drug Administration has approved CA 15-3 for
serial testing in women with prior stage II or III breast cancer who are
clinically free of disease.